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Abstract Innate and adaptive immune responses play
critical roles in the body’s defense against viruses. We
investigated the host immune response against the 2009
pandemic H1N1 influenza virus [A(H1N1)pdm09] in
patients before and after anti-influenza therapy and found
that the numbers of dendritic cells and T cells were sig-
nificantly reduced compared with those of a healthy control
group. In contrast, the frequency of natural killer, cdT and
T regulatory (Treg) cells increased, and the concentrations
of plasma interferon (IFN)-a/c and interleukin (IL-15)
were significantly higher than those of the control. Fol-
lowing therapy the frequency of cdT and Treg cells returned
to normal; the counts of myeloid dendritic and plasmacy-
toid dendritic cells were still lower than the control, while
the concentrations of IFN-a/c and IL-15 remained high.
We show that infection with A (H1N1)pdm09 was
accompanied by changes in peripheral blood lymphocyte
subgroups and cytokine profiles, leading to deleterious
imbalances in innate and adaptive immunity.
Introduction
The novel swine-origin pandemic 2009 influenza virus
[A(H1N1)pdm09] was first identified in April 2009. This
novel virus spread worldwide and had already caused about
17,000 deaths by the start of 2010 [14]. Data from the
Chinese Ministry of Health showed that there were 120,940
confirmed A(H1N1)pdm09 cases and 659 deaths reported
from the Chinese mainland as of January 2, 2010. The new
pandemic virus originated from a swine influenza virus
strain, which underwent multiple reassortment events in
pigs and was then transmitted to the human population [3,
15]. A(H1N1)pdm09 has gene segments from Eurasian
swine H1N1 viruses and a North American triple-reassor-
tant virus [3, 15]. Sequence analysis of this new pandemic
virus revealed that in the triple-reassortant virus, the hae-
magglutinin (HA), nucleoprotein (NP), and nonstructural
(NS) gene segments were derived from the classical swine
viruses, the polymerase basic 1 (PB1) segment was from
human H3N2 virus, and the polymerase basic 2 (PB2) and
polymerase acidic (PA) segments were from avian viruses
[3]. In addition, the neuraminidase (NA) and matrix
(M) segments originated from the Eurasian swine virus
lineage [3]. A(H1N1)pdm09 is genetically and antigeni-
cally distinct from previous seasonal human influenza A
viruses, and the majority of the human population does not
have pre-existing immunity to it.
A recent study showed that infection by A(H1N1)pdm09
was accompanied by a characteristic impairment of the
innate immune responses characterized by a selective
defect in cytokine responses to Streptococcus pneumoniae
[4]. Osterlund and colleagues also revealed that
A(H1N1)pdm09 was able to escape the host innate immune
response by interfering with antiviral and proinflammatory
cytokine gene expression in human macrophages and
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dendritic cells (DCs) [13]. DCs are crucial effector cells in
innate and adaptive immunity, and depending on the con-
text, they also induce T helper cell responses to infections
[6]. There are two main DC subsets that have been iden-
tified in humans, namely the CD85K?/CD(14 ? 16)-/low/
CD33? myeloid DCs (mDCs) and the CD85K?/
CD(14 ? 16)-/low/CD123? plasmacytoid DCs (pDCs) [10].
During viral infection, mDCs play an important role in
adaptive antiviral immune responses by taking up and
processing viral antigens into peptides for major histo-
compatibility complex (MHC) presentation to T cells in
secondary lymphoid organs, interacting with antigen-spe-
cific lymphocytes, activating T cells, B cells and natural
killer (NK) cells [1]. On the other hand, pDCs participate in
innate antiviral responses by rapidly producing large
amounts of interferon (IFN)-a type I when exposed to virus
infections, including influenza virus [8].
Infection by A(H1N1)pdm09 is also accompanied by
alterations in the adaptive immune responses. Reduction in
compartmentalization of CD4-lymphocytes, DCs and
B-lymphocytes, and increases in compartmentalization of
Treg cells have been observed in A(H1N1)pdm09-infected
patients. The decreases in CD4-lymphocyte, DCs and
B-lymphocyte compartmentalization occurred not only in
A(H1N1)pdm09-virus-infected patients but also in patients
with a flu-like syndrome. However, an increase of the
absolute counts of Treg cells was a principal finding in
A(H1N1)pdm09 infection when infection involved the lower
respiratory tract.
In this study, we investigated the effect of A(H1N1)
pdm09 infection on the pattern of innate and adaptive
immunity. We performed a longitudinal assessment of cellu-
lar compartmentalization in blood from untreated
A(H1N1)pdm09-infected patients and those following treat-
ment with either Chinese traditional medicines or paracetamol.
A direct enumeration of circulating mDC, pDC, NK cells and
cd T cells was performed in conjunction with an analysis of
CD4 T cell, CD8 T cell, B cell and Treg cell counts plus the
concentrations of plasma IFN-a/c and IL-15. We found that
A(H1N1)pdm09 infection was associated with a severe
impairment of the innate immune responses characterized by a
profound weakening of mDC and pDC subsets, which per-
sisted for a certain period after recovery from infection.
Materials and methods
Subjects
A total of 80 patients were first diagnosed by the Depart-
ment of Infectious Diseases in Guangdong Provincial
Hospital of Chinese Medicine from January to April 2011,
and throat swabs of the patients was tested using RT-PCR
by GDCDC (Guangdong Provincial Center for Disease
Control). All of the patients were confirmed as being
positive for A(H1N1)pdm09. These patients were not vac-
cinated before infection and did not present any other ill-
nesses. Patients were considered cured of A(H1N1)pdm09
infection when the symptoms had disappeared and labora-
tory tests for A(H1N1)pdm09 nucleic acid were negative
twice over a period of two days. With the agreement of each
patient, the following therapeutic regimens were proposed:
(1) treatment with Chinese traditional medicine, (2) treat-
ment with paracetamol, and (3) combined treatment with
Chinese traditional medicine and paracetamol.
In addition to A(H1N1)pdm09-infected patients,
45 gender- and aged-matched healthy individuals with no
reported influenza symptoms in the two months prior to the
study were enrolled as normal controls. All of the study
participants gave informed written consent. Venous blood
samples of the enrolled patients were collected in tubes
containing ethylenediaminetetraacetic acid (EDTA) before
and after therapy. Plasma prepared from blood was
collected in Eppendorf tubes and stored -80 C.
The Chinese traditional medicine consisted of the fol-
lowing herbal formulation: honeysuckle (15 g), mulberry
leaves (10 g), balloon flower (10 g), bamboo leaves (6 g),
peppermint (3 g), forsythia (15 g), chrysanthemum (10 g),
burdock (15 g), reed roots (30 g), and licorice roots (3 g).
This was given orally as a broth twice daily. Paracetamol
was given orally (60 mg/kg) at intervals of up to 4 hours.
The average duration of the therapy was 6 days.
Reagents and kits
The following reagents and kits were used in this study: qua-
druple-color fluorescence (FITC)/CD4-rhodamine (RD1)/
CD8-energy coupled dye (ECD)/CD3-phycoerythrin cyanin 5
(PeCy5); triple-color fluorescence-labeled mAbs CD3-FITC/
CD19-phycoerythrin(PE)/CD45-(PC5), CD(14 ? 16)-FITC/
CD85K-PE/CD33-PeCy5, and CD(14 ? 16)-FITC/CD85K-
PE/CD123-PeCy5; double-color fluorescence-labeled mAb
CD3-FITC/CD(16 ? 56)-PE; and single-color fluorescence-
labeled mAbs CD4-FITC, CD25- PeCy5, and CD127-PE.
OptiLyse C lysing solution, phosphate buffer solution (PBS),
and flow-count fluorospheres were also used. All of the above
mAbs and reagents were purchased from Beckman Coulter
(China). Enzyme-linked immunosorbent assay (ELISA) for
quantitative detection of human IFN-a, IFN-c and IL-15
(Bender MedSystems GmbH Campus Vienna Biocenter 2,
1030 Vienna, Austria) and ELISA for quantitative detection of
human interleukin 15 (IL-15) (R&D Systems, Inc., 614
McKinley Place NE, Minneapolis, MN 55413, United States
of America) were used.
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Flow cytometry and cytokine determination
One hundred microliters of whole blood from
A(H1N1)pdm09-infected patients or healthy controls were
collected in test tubes, and 20 ll of the appropriate fluo-
rochrome-conjugated antibody was added. After mixing,
the samples were incubated for 15 min at room tempera-
ture in the dark. Red blood cells were lysed using the
OptiLyse C lysing solution. For the absolute counts of DCs,
we added 100 ll of flow-count fluorospheres to the test
tubes with mDCs and pDCs before flow cytometry analy-
sis. Data were collected on a FC-500 (Beckman Coulter,
USA) flow cytometer. For cytokine determination in
plasma, the assays were performed in accordance with the
instructions of the manufacturers.
Statistical analysis
GraphPad Prism (GraphPad Software, Inc) was used to
create graphs, and data are shown as the mean ± SEM
(standard error of the mean). Student’s t-test was used to
evaluate the statistical significance between groups or
conditions, and differences were considered significant at
p \ 0.05.
Results
Clinical characteristics of the study group and healthy
controls
Among the 80 enrolled patients, thirty-eight were male and
forty-two were female. Their average age was 27 years
(range 19-35). A total of 45 healthy people were also
enrolled, nineteen of whom were male and twenty-six of
whom were female, with an average age of 26 (range
21-31).
As shown in Table 1, the gender ratio was analyzed
using the v2 test, and the other comparative data were
analyzed by the t-test. There were no statistical differences
(p [ 0.05) of the basal characteristics between the control
group and the A(H1N1)pdm09-infected patients.
The clinical characteristics of patients with
A(H1N1)pdm09 are summarized in Table 2. All of the
patients enrolled in the study had normal chest X-rays.
Nevertheless, all of them had fever and hyperpyrexia
symptoms, followed by expectoration in 56 patients
(70 %), nasal obstruction in 55 patients (69 %), sore throat
in 55 patients (69 %), cough 77 in patients (96 %), myalgia
in 64 patients (80 %), and headache in 59 patients (74 %).
Variation of circulating lymphocyte subsets between
untreated A(H1N1)pdm09-infected patients and infected
patients following therapy
Our results show that before the commencement of
therapy for A(H1N1)pdm09, the frequencies of CD3?,
CD4? and CD8? T cells in the patients were significantly
lower than those in healthy control individuals and in
patients following therapy (p \ 0.01). In contrast, the fre-
quencies of B cells (CD3- /CD19?) in the infected patients
prior to treatment were higher than those in the healthy
controls and the treated group (p \ 0.01) The ratio of
CD4?/CD8? was greater in pre-treatment patients com-
pared to the other two groups, but the difference was not
significant (p [ 0.05) (Table 3). In addition, our results
revealed that there was no significant difference in the
frequency of CD3?, CD4?, and CD8? T cells and B cells
(CD3- /CD19?) between A(H1N1)pdm09-infected patients
following therapy and the healthy individuals (p [ 0.05;
Table 3).
NK and cd T cells (phenotype: CD4- / CD8-) are non-
specific immune cells, and Treg regulatory cells have an
immune-suppressive function. They are made up of adap-
ted Treg cells (phenotype: CD4
? /CD25?) and natural Treg
cells (phenotype: CD4? /CD25? / CD127-). We also
investigated the changes in NK, cd T and Treg cell levels in
Table 1 Characteristics of patients and healthy controls
Characteristics Patients Healthy controls
Gender (male/female) 80 (38/42) 45 (19/26)
Age (mean ± SD, years) 27 ± 8 26 ± 5
Body height (mean ± SD, cm) 165.2 ± 7.8 164.5 ± 6.9
Body weight (mean ± SD, kg) 57.7 ± 11.2 55.2 ± 9.5
BMI (mean ± SD) 21.1 ± 3.3 21.1 ± 1.6
Table 2 Clinical characteristics of the 80 patients infected with
A(H1N1)pdm09
Characteristics and treatment Patients with
A(H1N1)pdm09 (n = 80)
Fever
T (37.5-38.5 C) N (%) 56 (70)
T [ 38.5 C N (%) 24 (30)
Nasal obstruction N (%) 55 (69)
Score throat N (%) 55 (69)
Cough N (%) 77 (96)
Myalgia N (%) 64 (80)
Headache N (%) 59 (74)
Expectoration N (%) 56 (70)
Treatment
Chinese medicine N (%) 34 (43)
Paracetamol N (%) 37 (46)
Combination of Chinese medicine and
paracetamol N (%)
9 (11)
Course of disease (mean ± SD, days) 6.27 ± 1.53
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the three study groups. Before therapy, the percentage of
NK, cd T and Treg cells was clearly elevated compared
with those of normal individuals and treated patients
(p \ 0.001). During the recovery phase, the proportion of
NK, cd T and Treg cells was significantly reduced com-
pared with those of patients prior to therapy (p \ 0.001),
while the differences between the A(H1N1)pdm09-infected
patients after therapy and the control group had no statis-
tical significance (p [ 0.05) (Fig. 1c and b).
Quantification of mDC and pDC
DCs play an important role in the first line defense against
viral infection [9]. Thus, we performed an absolute quan-
tification of mDC and pDC. The data showed that the
numbers of mDC and pDC in A(H1N1)pdm09-infected
patients without treatment significantly decreased com-
pared with the normal healthy controls and the treated
patients (p \ 0.001). Importantly, the numbers of mDCs
and pDCs in A(H1N1)pdm09-infected patients after ther-
apy were much higher than those before therapy
(p \ 0.001), although when compared to the healthy con-
trol group, the numbers were still lower (p \ 0.001)
(Fig. 1a).
Concentrations of IFN-a/c and IL-15 in blood plasma
To characterize the strength of the adaptive immune
response during A(H1N1)pdm09 infection, we examined
the concentrations of IFN-a/c and IL-15. Before therapy,
the concentrations of IFN-a/c and IL-15 in the blood of
A(H1N1)pdm09-infected patients were significantly higher
when compared with those of the healthy controls and
patients following therapy. As shown in Figure 1d, the
concentrations of IFN-a/c and IL-15 in A(H1N1)pdm09-
infected patients following therapy were significantly
lower when compared with those of patients before therapy
(p \ 0.001). However, when compared to the healthy
controls, the levels of IFN-a/c and IL-15 were still higher
(p \ 0.001).
Discussion
Infections triggered by influenza A(H1N1)pdm09 cause
illnesses ranging from mild upper and lower respiratory
tract syndromes to fatal diseases. The A(H1N1)pdm09
virus is a completely new reassortant virus, with gene
segments originating from different swine and avian
influenza viruses. For this reason, the human population
appears to have a limited immunity against the virus [3].
We therefore found it relevant to study the effect of this
novel virus on the human immune system.
In the present study, we have investigated the role of
innate and adaptive immune responses in patients infected
with A(H1N1)pdm09 by measuring changes in the num-
bers of mDCs, pDCs, NK cells, cd T cells, CD4? cells,
CD8? cells, and Treg cells in peripheral blood, as well as
IFN-a/c and IL-15 plasma levels. The parameters moni-
tored here included factors of the innate immune system
(pDCs, mDCs, NK cells, cdT cells, B cells), the adaptive
immune system (CD3 ? T, CD4 ? T, and CD8 ? T cells
and cytokines IFN-a/c and IL-15). We began by comparing
the variations in host immune responses before and after
anti-influenza therapy.
Our data revealed that during the acute phase of
A(H1N1)pdm09 infection, patients exhibited a significant
decrease in the absolute number of circulating DCs (mDCs
and pDCs). The importance of DCs in the initiation and
control of innate and adaptive immune responses to influ-
enza infection is well recognized [7]. During influenza
virus infection, DCs secrete antiviral cytokines to activate
CD4? and CD8? T cells through a specific response with
the production of neutralizing antibodies and secretion of
antiviral cytokines, such as IFN-c, which contribute to the
elimination of viral infection [7]. The different subpopu-
lations of DCs are both involved in the regulatory immune
mechanisms during influenza virus infection. mDCs are
characterized by a high susceptibility to influenza virus.
When infected by influenza virus, mDCs produce cytokines
such as TNF-a, IL-12, and IL-23 and may induce the
activation of specific cytotoxic CD8? T lymphocytes via
IL-15 [6]. pDCs are the main IFN-a-producing cells and
are essential for viral clearance [6]. During influenza virus
infection, pDCs and mDCs exhibited an equivalent effi-
ciency in stimulating anti–influenza virus cytotoxic T
lymphocytes [2].
Various possible mechanisms could be involved in
peripheral DC deficiency during A(H1N1)pdm09 infection.
One hypothesis is that these cells are more susceptible to
Table 3 The numbers of T and B lymphocytes and the ratio of
CD4?/CD8? T cells in untreated A(H1N1)pdm09-infected patients,







CD3? 54.95 ± 12.00
%**DD
68.39 ± 8.36 % 69.22 ± 7.19 %
CD3?CD4? 26.83 ± 8.01%**DD 34.35 ± 6.73 % 35.11 ± 5.22%
CD3?CD8? 20.52 ± 5.97
%**DD
25.40 ± 5.30 % 26.38 ± 3.47 %
CD3-CD19? 11.38 ± 4.13
%**DD
9.17 ± 3.39 % 8.15 ± 2.74 %
CD4?/CD8? 1.40 ± 0.55 1.42 ± 0.43 1.35 ± 0.27
** p \ 0.01 vs after therapy DD P \ 0.01 vs healthy controls
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apoptosis during A(H1N1)pdm09 infection. Recent studies
using mouse and human DCs in vitro demonstrate that,
upon infection, influenza virus blocks several features of
the DC maturation process, including synthesis of the
antiviral cytokine type I IFN together with a broad range of
inflammatory cytokines [11]. Moreover, virus-infected
DCs fail to up-regulate surface MHC class II and co-
stimulatory molecules such as CD80 and CD86 that are
pivotal for virus-specific CD4?and CD8? T cell stimula-
tion [12].
Another possible explanation could be due to the ele-
vation of Treg cells. In agreement with a study conducted
by Evangelos et al. [5], during the acute phase of
A(H1N1)pdm09 virus infection, our patients exhibited a
significant increase of Treg numbers in their blood. Treg
cells suppress a variety of physiological and pathological
immune responses. From a functional perspective, several
mechanisms of Treg-mediated suppression have been
proposed, and these include the following aspects: (1)
Upon antigenic stimulation, antigen-specific Treg cells,
which are highly mobile, are swiftly recruited via che-
mokines to dendritic cells, presenting the antigen and out-
competing antigen-specific naive T cells in aggregating
around the dendritic cells. (2) Antigen-activated Treg cells
contacting dendritic cells then modulate DC maturation
and/or function such as lymphocyte-activation gene
3–MHC-class-II mediated suppression of DC maturation,
and cytotoxic T-lymphocyte antigen-4-CD80/CD86-
mediated induction of human indoleamine 2,3-
dioxygenase protein (IDO), which is an immunosuppres-
sive molecule made by DCs [15]. (3) Treg cells could
secrete granzyme/perforin, IL-10, or other immunosup-
pressive cytokines (such as TGF-b and IL-35) to dampen
immune responses.
Consistent with an increase in the number of Treg cells,
our patients in the acute phase of disease showed a sig-
nificant decrease in absolute numbers of CD4? and CD8?
T cells. However, the level of plasma IFN-a/c, which plays
a part in restricting the replication of the virus and initi-
ating the adaptive immune responses, was significantly
increased in our patients at the initial stage of
A(H1N1)pdm09 infection [13]. In addition, the numbers of
NK, cdT, and B cells in blood from our patients in the
acute phase of disease were beyond the normal range,
which is contrary to the observation in severe
A(H1N1)pdm09 infection cases. After therapy,
A(H1N1)pdm09-infected patients achieved a complete
recovery of CD4? T cells and CD8? T cells, but DC count
values remained significantly lower than in healthy con-
trols after therapy.
In summary, our study demonstrates that
A(H1N1)pdm09 infection alters the innate and adaptive
immune responses through an increase in Treg cells and a
reduction in DCs and T cells. We believe that this is the
first time that variation in the host response to infection
with A(H1N1)pdm09 before and after anti-influenza ther-
apy has been studied, providing new information on the
A(H1N1)pdm09 infection process.
Fig. 1 Analysis of the changes
in adapted Treg cells, natural
Treg cells, NK cells, cdT cells,
DCs and cytokines in the
peripheral blood of
A(H1N1)pdm09-infected
patients before and after therapy
and healthy controls. Adapted
Treg, natural Treg, NK, Tcd cells
are presented as a percentage of
total peripheral blood
lymphocytes in patients infected
with A(H1N1) pdm09 (n = 80)
and healthy individuals
(n = 45). Absolute counts of
mDCs and pDCs are presented
in total peripheral blood in
patients infected with
A(H1N1)pdm09 (n = 80) and
healthy individuals (n = 45).
Error bars represent SEM. ***
p \ 0.001
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